|
Feb 17
|
|
$946.47
$946.97
+0.1%
|
N/A
|
Finnhub News
|
— |
Finnhub - MCK
Is Wall Street Bullish or Bearish on McKesson...
|
|
Feb 17
|
|
$946.47
$946.97
+0.1%
|
N/A
|
Finnhub News
|
— |
Finnhub - MCK
2 Surging Stocks to Own for Decades and 1 We...
|
|
Feb 16
|
|
$934.75
$946.97
+1.3%
|
N/A
|
Finnhub News
|
— |
Finnhub - MCK
2 Momentum Stocks Worth Your Attention and 1...
|
|
Feb 15
|
|
$934.75
$946.97
+1.3%
|
N/A
|
Finnhub News
|
— |
Finnhub - MCK
Is There An Opportunity With McKesson Corpora...
|
|
Feb 13
|
|
$934.75
$946.97
+1.3%
|
N/A
|
Finnhub News
|
— |
Finnhub - MCK
Will ISRG's R&D Focus Following Solid Earning...
|
|
Feb 07
|
|
$948.68
$946.97
-0.2%
|
LONG
|
Jim Cramer
Host, Mad Money
|
Medical distributors and managed care are performing well. * McKesson (MCK) & Cardinal Health (CAH): "Classic drug middlemen." They are consistent winners; buy them anytime they dip. * CVS Health (CVS): The only health insurer to own. It is now the last real national drugstore chain (with Walgreens private and Rite Aid closed) and is undervalued as a managed care play. |
CNBC
Mad Money 02/06/26 | Audio Only
|